GLP1R and type 2 diabetes mellitus: Therefore, after some biomedical modifications for achieving enhanced therapeutic efficiency and sustained effects, GLP-1R agonists have been widely used in the clinical treatment of type 2 diabetes mellitus (T2DM) as well as clinical evaluation of obesity [11].